(R)-N-(1-(3-amino-4-chloro-5-methylbenzo[d]isoxazol-7-yl)pyrrolidin-3-yl)-2-chloro-4-(4H-1,2,4-triazol-4-yl)benzamide

ID: ALA4099310

PubChem CID: 118457032

Max Phase: Preclinical

Molecular Formula: C21H19Cl2N7O2

Molecular Weight: 472.34

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(N2CC[C@@H](NC(=O)c3ccc(-n4cnnc4)cc3Cl)C2)c2onc(N)c2c1Cl

Standard InChI:  InChI=1S/C21H19Cl2N7O2/c1-11-6-16(19-17(18(11)23)20(24)28-32-19)29-5-4-12(8-29)27-21(31)14-3-2-13(7-15(14)22)30-9-25-26-10-30/h2-3,6-7,9-10,12H,4-5,8H2,1H3,(H2,24,28)(H,27,31)/t12-/m1/s1

Standard InChI Key:  WRLGJSVRFOTDKJ-GFCCVEGCSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   21.0186  -10.7390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0174  -11.5585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7255  -11.9675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4351  -11.5581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4323  -10.7354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7237  -10.3301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3108  -10.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3106   -9.5134    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.6031  -10.7394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8953  -10.3309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8093   -9.5193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0099   -9.3496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6015  -10.0574    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1485  -10.6645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7908  -10.1448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3107   -9.4822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4987   -9.5674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1658  -10.3147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4613  -10.8889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6475  -10.9815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4840  -11.7840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1968  -12.1875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8006  -11.6343    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7403  -12.1227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7212   -9.5130    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   23.1435  -11.9656    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2307  -12.7757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0303  -12.9444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.4378  -12.2360    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8900  -11.6296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3530  -10.3989    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.0185   -8.9062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  2  0
  7  9  1  0
 10  9  1  1
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 20  1  0
 19 15  1  0
 13 15  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 19  1  0
 21 24  1  0
  6 25  1  0
  4 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 26  1  0
 18 31  1  0
 17 32  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

F9 Tchem Coagulation factor IX (922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 472.34Molecular Weight (Monoisotopic): 471.0977AlogP: 3.61#Rotatable Bonds: 4
Polar Surface Area: 115.10Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.61CX LogP: 2.58CX LogD: 2.58
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.47Np Likeness Score: -1.75

References

1. Sakurada I, Endo T, Hikita K, Hirabayashi T, Hosaka Y, Kato Y, Maeda Y, Matsumoto S, Mizuno T, Nagasue H, Nishimura T, Shimada S, Shinozaki M, Taguchi K, Takeuchi K, Yokoyama T, Hruza A, Reichert P, Zhang T, Wood HB, Nakao K, Furusako S..  (2017)  Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors.,  27  (11): [PMID:28408226] [10.1016/j.bmcl.2017.03.002]

Source